Rome, 20 June. (Adnkronos Health) – “As far as HIV therapy is concerned, we are very advanced. We have extremely powerful and safe drugs for the patient which, if started very early and taken correctly by the patient, on the one hand manage to prevent the virus causes damage within our organism, on the other hand they freeze viral replication, blocking the ability of the virus to reproduce within our organism and, as a consequence, preventing the virus from being transmitted to other people”. Thus Simone Lanini, professor at the University of Udine, on the occasion of the ‘Hiv. Let’s talk about it again!’, a moment of discussion and sharing to talk about therapeutic adherence, U=U and resistance promoted by Gilead Sciences on the occasion of the Icar Congress – Italian conference on aids and antiviral research. Now in its 16th edition, whose claim is ‘Research and care: from bench, to bedside, to community’, the congress promotes reflection on the importance of research to achieve global care for the person.
“This is a very important concept – concludes Lanini – which today is spread with the slogan U=U, i.e. Undetectable = Untransmittable, which means that the patient who is treated and takes the therapy correctly does not can under no circumstances transmit the infection to other people.”
